Pharma-Bio Serv (OTCMKTS:PBSV) Announces Quarterly Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSV) issued its earnings results on Monday. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.35, reports. The business had revenue of $2.47 million during the quarter, compared to analyst estimates of $2.70 million. Pharma-Bio Serv had a negative return on equity of 5.61% and a negative net margin of 8.18%.

Pharma-Bio Serv Price Performance

Shares of PBSV opened at $0.43 on Wednesday. The firm has a market cap of $9.86 million, a P/E ratio of -14.33 and a beta of 0.53. Pharma-Bio Serv has a 1 year low of $0.31 and a 1 year high of $0.90. The stock has a 50 day simple moving average of $0.55 and a two-hundred day simple moving average of $0.57.

Pharma-Bio Serv Dividend Announcement

The company also recently announced a dividend, which will be paid on Thursday, March 20th. Shareholders of record on Friday, February 28th will be paid a $0.075 dividend. The ex-dividend date is Friday, February 28th. Pharma-Bio Serv’s dividend payout ratio is currently -250.00%.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.